Medmo receives $9M investment for radiology scan scheduling

Medical imaging technology company Medmo has successfully raised $9 million. The new funding round was led by early stage venture capital firm Lerer Hippeau, with participation from existing investors.

According to an announcement, the newly secured funds are earmarked to expedite Medmo's ongoing expansion and the development of its existing radiology patient scheduling platform. 

Medmo's platform aims to help providers simplify patient scheduling by bringing all radiology intake to one platform that allows for the scheduling of various imaging exams, such as MRIs, CTs, mammograms, ultrasounds and X-rays, helping provider organizations to match patients with an imaging center for rapid testing. 

“Investor capital in healthcare has often focused on high-tech solutions to improve diagnostic assessments, but that approach ignores a crucial first step: connecting patients with accessible care,” Isabelle Phelps, partner at Lerer Hippeau, said in the announcement. “Medmo removes the cost and logistical barriers to diagnostics, improving imaging order completion rates and subsequent quality of care.”

Medmo’s platform is currently deployed across various healthcare settings nationwide. The company caters to primary care groups, large multi-specialty health systems, and virtual health groups.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.